Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03043755
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AEJ | (1S)-1-{4-[(9AR)-OCTAHYDRO-2H-PYRIDO[1,2- A]PYRAZIN-2-YL]PHENYL}-2-PHENYL- 1,2,3,4-TETRAHYDROISOQUINOLIN-6- OL | A,B,C,D | 1XQC | 0.74 |  |
REN | (S)-reticuline | A | 3FWA | 0.86 | |
| REN | (S)-reticuline | A | 3D2D | 0.86 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.75 | |
| ALE | L-EPINEPHRINE | A | 2HKK | 0.75 | |
AED | 4-(2-aminoethyl)-2-cyclohexylphenol | A | 3BUH | 0.71 | |
AHT | 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)- PHENOL | I,T | 1TMB | 0.71 | |
RHP | (3R)-3-(PROP-2-YNYLAMINO)INDAN- 5-OL | A,B | 1S3E | 0.77 | |
GNT | (-)-GALANTHAMINE | A | 1DX6 | 0.7 | |
| GNT | (-)-GALANTHAMINE | A | 1QTI | 0.7 | |
| GNT | (-)-GALANTHAMINE | A,B,C,D,E | 2PH9 | 0.7 | |
| GNT | (-)-GALANTHAMINE | A,B | 1W76 | 0.7 | |
| GNT | (-)-GALANTHAMINE | A | 1W6R | 0.7 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.71 | |
MA0 | (1R)-6-HYDROXY-N-METHYL-N-[(1Z)- PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM | A,B | 2C64 | 0.72 | |
AB8 | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4- HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)- 2-OXOETHYL]-2-OXO-1,3-OXAZINAN- 6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A- HEXAHYDRONAPHTHALEN-1-YL (2R)-2- METHYLBUTANOATE | A,B | 1XDG | 0.7 | |
OI1 | 3-(4-HYDROXYBENZYL)-2-[1-({[2-(4- HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]- 4-OXO-3,6,11,11A-TETRAHYDRO-4H- PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM- 1-OLATE | A,B | 1Q9D | 0.71 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.8 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.75 | |
| SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.75 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.76 | |
| LDP | L-DOPAMINE | A | 5PAH | 0.76 | |
| LDP | L-DOPAMINE | A,B | 2QMZ | 0.76 | |
| LDP | L-DOPAMINE | A,B | 2VQ5 | 0.76 | |
MDW | (1R)-N,6-DIHYDROXY-7-METHOXY-2- [(4-METHOXYPHENYL)SULFONYL]-1,2,3,4- TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE | A | 2DDY | 0.71 | |
DPD | A,B | 1QIW | 0.75 | | |
| DPD | A | 1QIV | 0.75 | | |
BM4 | 3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl- 3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan- 3-yl]phenol | X | 2W6C | 0.74 | |
LNR | L-NOREPINEPHRINE | A,B | 2QEO | 0.72 | |
| LNR | L-NOREPINEPHRINE | A | 3DYE | 0.72 | |
| LNR | L-NOREPINEPHRINE | A | 4PAH | 0.72 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.71 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.71 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.71 | |
MOI | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A- HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2- E]ISOQUINOLINE-7,9-DIOL | H,L | 1Q0Y | 0.71 | |